Key Takeaways
- Approximately 250,000 coronary artery bypass graft (CABG) surgeries are performed annually in the US
- In 2019, over 400,000 open heart surgeries were conducted worldwide for valvular heart disease
- CABG accounts for 60% of all open heart surgeries in adults over 65
- Elective CABG surgery has a 98% success rate in low-risk patients
- 5-year graft patency for left internal mammary artery is 90-95%
- Overall survival post-CABG is 85% at 10 years
- Operative mortality for isolated CABG is 1.2%
- 30-day mortality for emergency CABG is 8-10%
- 1-year survival post-mitral valve surgery is 92%
- Stroke occurs in 1-2% of CABG patients
- Atrial fibrillation post-op affects 30-40% of open heart surgery patients
- Renal failure requiring dialysis happens in 2-5% of cases
- Average ICU stay after uncomplicated CABG is 1-2 days
- Full recovery takes 6-12 weeks for most patients
- Cardiac rehab participation improves survival by 20%
Open heart surgery is widely performed with high success rates and consistent patient recovery.
Complications
- Stroke occurs in 1-2% of CABG patients
- Atrial fibrillation post-op affects 30-40% of open heart surgery patients
- Renal failure requiring dialysis happens in 2-5% of cases
- Deep sternal wound infection rate is 1-3%
- Reoperation for bleeding occurs in 3-5% of patients
- Prolonged ventilation >24 hours in 10% of CABG cases
- Delirium incidence is 20-30% post-open heart surgery
- Myocardial infarction post-op rate is 2-4%
- Pneumonia develops in 5-10% of patients
- Leg wound infection from vein harvest in 5-10%
- Pleural effusion requiring drainage in 2%
- Sepsis post-op in 1-2%
- Tamponade 1-2%
- GI bleed 2%
- VT/VF arrhythmia 5-10%
- Phrenic nerve injury 5%
- Low output syndrome 5%
- Chylothorax <1%
- Mesenteric ischemia 1%
- Lymphatic fistula 0.5-1%
Complications Interpretation
Complications, source url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123941/
- Hyperglycemia >200mg/dL in 50%, category: Complications
Complications, source url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123941/ Interpretation
Epidemiology and Incidence
- Approximately 250,000 coronary artery bypass graft (CABG) surgeries are performed annually in the US
- In 2019, over 400,000 open heart surgeries were conducted worldwide for valvular heart disease
- CABG accounts for 60% of all open heart surgeries in adults over 65
- Annual incidence of open heart surgery for aortic valve replacement is about 50,000 in Europe
- In the US, 1 in 200 adults over 40 undergo open heart surgery yearly
- Mitral valve surgery represents 20% of open heart procedures globally
- Over 100,000 CABG surgeries occur in patients with diabetes annually in the US
- Pediatric open heart surgeries number around 12,000 per year in the US
- CABG rates have declined 20% from 2000 to 2018 due to PCI rise
- In 2022, India performed over 50,000 open heart surgeries
- In 2020, approximately 280,000 CABG surgeries were performed in the US
- Global open heart surgeries exceed 1 million annually
- Aortic valve replacement surgeries number 100,000/year in US/Europe
- Women comprise 25% of CABG patients
- Congenital heart defect repairs: 40,000 pediatric cases/year US
- CABG utilization peaked at 400,000 in 1990s US
- Asia accounts for 40% of global open heart volume
- Emergency open heart surgeries: 15% of total volume
- Patients over 80: 20% of CABG recipients
- Hypertrophic cardiomyopathy surgeries: 5,000/year worldwide
Epidemiology and Incidence Interpretation
Mortality and Survival
- Operative mortality for isolated CABG is 1.2%
- 30-day mortality for emergency CABG is 8-10%
- 1-year survival post-mitral valve surgery is 92%
- In-hospital mortality for aortic dissection surgery is 15-20%
- 5-year survival after CABG in octogenarians is 70%
- Perioperative mortality for redo open heart surgery is 5.5%
- 10-year survival for CABG vs medical therapy is 79% vs 62%
- Mortality risk increases 1.5% per year of age in CABG patients
- Postoperative mortality for endocarditis valve surgery is 12%
- Overall 30-day mortality for all open heart surgeries is 2.5%
- 5-year mortality for CABG in diabetics is 10%
- Isolated AVR mortality 1.5%
- CABG + AVR combined mortality 4%
- 20-year survival post-CABG 40%
- Mortality in women higher by 1-2% vs men
- Acute MI CABG mortality 5%
- Pediatric open heart mortality <1% for simple defects
- High-risk EuroSCORE >10% mortality doubles to 10%
- 90-day mortality for Type A dissection 20%
- Long-term survival benefit CABG over PCI 15%
Mortality and Survival Interpretation
Recovery and Rehabilitation
- Average ICU stay after uncomplicated CABG is 1-2 days
- Full recovery takes 6-12 weeks for most patients
- Cardiac rehab participation improves survival by 20%
- 80% of patients return to work within 3 months
- Pain scores decrease to baseline by 4 weeks post-op
- Sternotomy healing occurs in 90% by 6 weeks
- Exercise capacity doubles by 3 months with rehab
- Depression rates drop from 30% pre-op to 10% at 6 months
- 95% achieve NYHA class I/II by 1 year
- Weight loss of 5-10% common in first month due to rehab diet
- Driving resumption average 4-6 weeks post-surgery
- Hospital stay averages 7-10 days for CABG
- 70% resume normal activities by 8 weeks
- Rehab reduces rehospitalization by 30%
- Sexual activity resumption 6-8 weeks
- Grip strength returns to baseline at 3 months
- 60% adherence to rehab programs
- Anxiety decreases 50% by 3 months
- VO2 max improves 20-30% post-rehab
- Incision scar fades by 12 months in 90%
- Medication compliance 85% at 1 year
Recovery and Rehabilitation Interpretation
Surgical Outcomes
- Elective CABG surgery has a 98% success rate in low-risk patients
- 5-year graft patency for left internal mammary artery is 90-95%
- Overall survival post-CABG is 85% at 10 years
- Valve repair success rate exceeds 95% for degenerative mitral regurgitation
- Hospital discharge rate after open heart surgery is 96% for CABG
- Freedom from reoperation after aortic root replacement is 92% at 10 years
- CABG improves quality of life scores by 75% at 1 year post-op
- 30-day readmission-free rate is 88% after elective CABG
- Symptomatic relief in 90% of angina patients post-CABG
- Long-term ejection fraction improvement in 70% of CABG patients with low EF
- 95% graft patency at 1 year for saphenous vein
- Mitral valve repair durability 95% at 20 years
- 90% angina-free survival at 5 years post-CABG
- Functional improvement in 85% of low EF patients
- 98% discharge to home for low-risk valve surgery
- Bicuspid aortic valve repair success 92%
- Quality-adjusted life years gained: 3.5 per CABG
- Event-free survival 80% at 5 years for multivessel disease
- Ross procedure success 95% at 20 years
- Symptom resolution in 92% post-tricuspid repair
Surgical Outcomes Interpretation
Technological Advances and Techniques
- Minimally invasive CABG reduces hospital stay by 2-3 days
- Robotic-assisted mitral valve repair success rate 95%
- Off-pump CABG avoids CPB in 20-30% of cases
- TAVR hybrid with open surgery reduces recovery time by 50%
- 3D printing used in 10% of complex congenital repairs
- Intraoperative ECMO support in 5% of high-risk cases
- Transcatheter valve-in-valve procedures replace 15% open surgeries
- AI predicts outcomes with 90% accuracy pre-op
- Endoscopic vein harvest reduces leg complications by 50%
- CPB time averages 90-120 minutes for standard CABG
- Hybrid OR use cuts recovery by 20%
- Beating heart surgery 25% of CABGs now
- Fluorescence imaging improves vein harvest accuracy 95%
- Percutaneous CPB cannulation in 10% high-risk
- VR training reduces errors by 40%
- Bioengineered grafts in trials show 90% patency
- Intra-op OCT for valve assessment 85% use
- FAST ultrasound cuts ventilation time 20%
- Nanotechnology coatings reduce thrombosis 70%
- Machine perfusion for grafts extends viability 24 hours
Technological Advances and Techniques Interpretation
Sources & References
- Reference 1HEARTheart.orgVisit source
- Reference 2NCBIncbi.nlm.nih.govVisit source
- Reference 3CDCcdc.govVisit source
- Reference 4ACADEMICacademic.oup.comVisit source
- Reference 5AHAJOURNALSahajournals.orgVisit source
- Reference 6JTCVSjtcvs.orgVisit source
- Reference 7DIABETESJOURNALSdiabetesjournals.orgVisit source
- Reference 8JAMANETWORKjamanetwork.comVisit source
- Reference 9MAYOCLINICmayoclinic.orgVisit source
- Reference 10NEJMnejm.orgVisit source
- Reference 11JACCjacc.orgVisit source
- Reference 12ANNALSTHORACICSURGERYannalsthoracicsurgery.orgVisit source
- Reference 13STSsts.orgVisit source
- Reference 14MYmy.clevelandclinic.orgVisit source
- Reference 15HOPKINSMEDICINEhopkinsmedicine.orgVisit source
- Reference 16NHSnhs.ukVisit source





